Ceftolozane/tazobactam for pulmonary exacerbation in a 63-year-old cystic fibrosis patient with renal insufficiency and an elevated MIC to Pseudomonas aeruginosa

Cystic fibrosis (CF) is a progressive genetic disorder caused by mutations in a gene encoding the cystic fibrosis transmembrane regulator (CFTR) protein leading to persistent and difficult to treat lower airway infections. Multi-drug resistant Pseudomonas aeruginosa is becoming increasingly more com...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Meredith Tate Romano, Sasha Premraj, John M. Bray, Luis C. Murillo
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2020-01-01
Colecção:	IDCases
Assuntos:	Ceftolozane/tazobactam Cystic fibrosis Therapeutic drug monitoring
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2214250920301384
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!